Loading...
Efficacy and safety of concurrent chemoradiotherapy with or without Nimotuzumab in unresectable locally advanced squamous cell carcinoma of head and neck: Prospective comparative study - ESCORT-N study
BACKGROUND: Nimotuzumab is an anti-epidermal growth factor receptor monoclonal antibody which can be added to chemoradiotherapy (CRT) to improve efficacy for management of locally advanced squamous cell carcinoma of the head and neck (LASCCHN). We prospectively evaluated the efficacy and safety of n...
Na minha lista:
| Udgivet i: | South Asian J Cancer |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Wolters Kluwer - Medknow
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6498712/ https://ncbi.nlm.nih.gov/pubmed/31069191 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/sajc.sajc_38_18 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|